Keloids Treatment Market Report 2026

Keloids Treatment Market Overview

• Keloids Treatment market size has reached to $4.32 billion in 2025 • Expected to grow to $5.37 billion in 2030 at a compound annual growth rate (CAGR) of 4.6% • Growth Driver: Surge In Wound And Injury Cases Fuels Keloid Treatment Market Growth • Market Trend: Innovative Silicone Scar Treatment Solutions Redefines The Keloid Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Keloids Treatment Market?

Keloids refer to raised, thickened scars that extend beyond the original boundaries of a wound or injury. These scars result from an overgrowth of collagen during the healing process, leading to a firm, often discolored and sometimes uncomfortable or itchy area on the skin. Keloids can be treated using various medical interventions and approaches tailored to the individual's condition and the severity of the keloid. The main types of keloids treatment are radiation therapy, cryotherapy, surgical treatment, laser treatment, steroid injections, interferon and others. Radiation therapy is a medical treatment that uses high doses of targeted radiation to target and destroy abnormal cells, such as keloid cells, aiming to inhibit the overgrowth of cells and reduce the size of keloids, which helps prevent keloid recurrence by damaging the cells that contribute to their formation. Keloids treatment also includes products such as elastic wraps, sprays, ointments, creams, oils, topical gels and gel sheets and others administered orally and parenterally by end users such as hospitals, homecare, dermatology clinics and others.

What Is The Keloids Treatment Market Growth Forecast?

The keloids treatment market size is expected to see steady growth in the next few years. It will grow to $5.37 billion in 2030 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to advancement in laser and cryotherapy technologies, growing awareness of scar management solutions, rising preference for minimally invasive treatments, expansion of dermatology clinics in emerging markets, increasing adoption of homecare scar products. Major trends in the forecast period include rising demand for non-invasive keloid treatments, growing adoption of combination therapy approaches, increasing use of laser-based scar management, expansion of homecare and topical treatment options, focus on personalized and recurrence-preventive therapies.

What Are The Drivers Of The Keloids Treatment Market?

The rising incidence of wound and injury cases is expected to propel the growth of the keloid treatment market going forward. A wound is a physical injury or damage to the body's tissues, typically involving a break in the skin, resulting from various causes such as accidents, surgical procedures, burns, or other traumatic events. The rise in experienced wounds leads to keloid formation, increasing demand for effective treatment options, fostering greater awareness about keloid complications, encouraging research advancements and promoting collaboration among medical professionals. For instance, in November 2024, according to the U.S. Bureau of Labor Statistics (BLS), a US-based federal government agency responsible for producing essential labor market and workplace safety data, private industry employers reported about 2.6 million nonfatal workplace injuries and illnesses in 2023. Therefore, the rising incidence of wound and injury cases will drive the growth of the keloid treatment market. The increasing interest in non-surgical aesthetic procedures is expected to propel the keloid treatment market forward. Non-surgical aesthetics are cosmetic treatments that enhance appearance without surgery, addressing specific concerns for a more youthful look. Healthcare providers use non-surgical aesthetic procedures such as laser therapy, cryotherapy, and dermal fillers to alleviate the appearance and symptoms of keloid scars, reducing inflammation, redness, and vascularization. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based nonprofit organization representing board-certified plastic surgeons, total surgical and non-surgical aesthetic procedures rose by 3.4% in 2023 to reach about 34.9 million, including approximately 19.1 million non-surgical treatments. Therefore, rising demand for non-surgical aesthetic procedures will drive the keloid treatment market.

Key Players In The Global Keloids Treatment Market

Major companies operating in the keloids treatment market are Galderma S.A., Sun Pharmaceutical Industries Ltd., Stratpharma AG, Revance Therapeutics Inc., Sensus Healthcare Inc., Cynosure Inc., Cutera Inc., Lumenis Ltd., Candela Medical, Merz Pharma GmbH & Co. KGaA, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Alliance Pharma plc, Sonoma Pharmaceuticals Inc., Strata Skin Sciences Inc., Avita Medical Limited, Biofrontera AG, Sinclair Pharma plc, Fotona d.o.o., Lutronic Corporation

Global Keloids Treatment Market Trends and Insights

Major companies operating in the keloid treatment market are focused on developing innovative scar management technologies, such as scar-erase silicone strips, to gain competitive advantages in the market. For instance, in April 2023, Scar Erase, a UK-based scar treatment company, launched Scar Erase silicone strips as a solution for treating scars. These are made from 3 mm of medical-grade silicone and have been clinically proven to improve scar appearance and promote healing. These reusable, vegan and cruelty-free technology strips are designed to offer an affordable and convenient at-home scar treatment option suitable for various scar types, including hypertrophic, keloid, post-surgery and stretch marks. It also involves encapsulating the scar with silicone to hydrate it and create an optimal healing environment. This reduces collagen formation and improves scar texture, color and height, providing effectiveness and comfort.

What Defines the Keloids Treatment Market?

The keloids treatment market consists of revenues earned by entities by providing dermatology consultations, follow-up and monitoring and patient education and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The keloids treatment market also includes sales of topical creams and gels, silicone sheets and patches and dermal fillers, which are used in keloids treatment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Keloids Treatment Market Report 2026?

The keloids treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the keloids treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.